Role of Tivozanib in Renal Cell Carcinoma (RCC) - Episode 2
Dr Thomas Hutson reviews the TIVO-3 trial, including the most recent data that was presented at ASCO GU.
Direct-to-Bladder Immunotherapy Drug to Be Studied in Bladder Cancer
Chemo Combo Adds More to the Treatment Toolbox for Advanced Pancreatic NETs
Anniversary Time: A Look Back of What I’ve Learned 10 Years After Cancer
Taking 8-Plus Medications Before Cancer Treatment May Affect Effectiveness in Older Patients